Glycans in virus-host interactions: A structural perspective

NL Miller, T Clark, R Raman… - Frontiers in molecular …, 2021 - frontiersin.org
Many interactions between microbes and their hosts are driven or influenced by glycans,
whose heterogeneous and difficult to characterize structures have led to an …

Can we improve vaccine efficacy by targeting T and B cell repertoire convergence?

K Fink - Frontiers in Immunology, 2019 - frontiersin.org
Traditional vaccine development builds on the assumption that healthy individuals have
virtually unlimited antigen recognition repertoires of receptors in B cells and T cells [the B …

Cross-reactivity and anti-viral function of dengue capsid and NS3-specific memory T cells toward zika virus

MQ Lim, EAP Kumaran, HC Tan, DC Lye… - Frontiers in …, 2018 - frontiersin.org
Zika virus (ZIKV), a flavivirus with homology to dengue virus (DENV), is spreading to areas of
DENV hyper-endemicity. Heterologous T cell immunity, whereby virus-specific memory T …

Learned features of antibody-antigen binding affinity

NL Miller, T Clark, R Raman… - Frontiers in Molecular …, 2023 - frontiersin.org
Defining predictors of antigen-binding affinity of antibodies is valuable for engineering
therapeutic antibodies with high binding affinity to their targets. However, this task is …

Zika Virus NS5 forms supramolecular nuclear bodies that sequester importin-α and modulate the host immune and pro-inflammatory response in neuronal cells

IHW Ng, KWK Chan, MJA Tan, CP Gwee… - ACS infectious …, 2019 - ACS Publications
The Zika virus (ZIKV) epidemic in the Americas was alarming because of its link with
microcephaly in neonates and Guillain-Barré syndrome in adults. The unusual pathologies …

Enhancing antibody affinity through experimental sampling of non-deleterious CDR mutations predicted by machine learning

T Clark, V Subramanian, A Jayaraman… - Communications …, 2023 - nature.com
The application of machine learning (ML) models to optimize antibody affinity to an antigen
is gaining prominence. Unfortunately, the small and biased nature of the publicly available …

Phase 1 trial of a therapeutic anti–yellow fever virus human antibody

JG Low, JHJ Ng, EZ Ong, S Kalimuddin… - … England Journal of …, 2020 - Mass Medical Soc
Background Insufficient vaccine doses and the lack of therapeutic agents for yellow fever put
global health at risk, should this virus emerge from sub-Saharan Africa and South America …

A review on the current knowledge on ZIKV infection and the interest of organoids and nanotechnology on development of effective therapies against Zika infection

S Gasco, MÁ Muñoz-Fernández - International Journal of Molecular …, 2020 - mdpi.com
Zika virus (ZIKV) acquired a special relevance due to the pandemic that occurred in the
Americas in 2015, when an important number of fetal microcephaly cases occurred. Since …

Optimizing antibody affinity and developability using a framework–CDR shuffling approach—application to an anti-SARS-CoV-2 antibody

R Gopal, E Fitzpatrick, N Pentakota, A Jayaraman… - Viruses, 2022 - mdpi.com
The computational methods used for engineering antibodies for clinical development have
undergone a transformation from three-dimensional structure-guided approaches to artificial …

Clinical and experimental evidence for transplacental vertical transmission of flaviviruses

S Watanabe, SG Vasudevan - Antiviral Research, 2023 - Elsevier
The Zika virus (ZIKV) epidemic outbreak in Americas in 2016 attracted global attention
because of the association of the virus infection with severe birth defects such as …